Okimoto 2009.

Methods	Prospective, randomised trial.
Participants	50 elderly patients (mean age 80 years; 60% male) with community‐acquired pneumonia.
Interventions	Meropenem 500 mg i.v. q12h vs meropenem 1.0 g/day i.v. continuous 24 h infusion; mean treatment duration 12 to 13 days.
Outcomes	Clinical efficacy. Bacteriological efficacy.
Notes	Able to obtain only partial translation of this trial from Japanese into English.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Randomly assigned, but unclear randomisation method.
Allocation concealment (selection bias)	Unclear risk	Unclear, complete translation not available.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Unclear, complete translation not available.
Incomplete outcome data (attrition bias) All outcomes	Low risk	All patients assessed for clinical cure, but not for bacteriological efficacy.
Selective reporting (reporting bias)	Unclear risk	Unclear; complete translation not available.
Other bias	Unclear risk	Unclear; complete translation not available.